Venus Concept (NASDAQ:VERO) has received an average broker rating score of 2.00 (Buy) from the two analysts that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a hold recommendation and one has given a strong buy recommendation to the company. Venus Concept’s rating score has improved by 33.3% from three months ago as a result of various analysts’ upgrades and downgrades.

Brokers have set a one year consensus target price of $15.00 for the company and are anticipating that the company will post ($0.37) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Venus Concept an industry rank of 102 out of 255 based on the ratings given to its competitors.

A number of equities analysts have recently issued reports on the company. Oppenheimer assumed coverage on Venus Concept in a research note on Friday. They set an “outperform” rating for the company. Maxim Group raised Venus Concept from a “hold” rating to a “buy” rating and set a $10.00 target price for the company in a research note on Thursday, January 9th.

Shares of VERO stock traded down $0.08 during trading hours on Thursday, reaching $7.11. 2,664 shares of the company’s stock were exchanged, compared to its average volume of 127,114. The company has a market cap of $197.58 million, a price-to-earnings ratio of -0.54 and a beta of 4.14. Venus Concept has a 1 year low of $2.63 and a 1 year high of $23.25.

Venus Concept (NASDAQ:VERO) last issued its earnings results on Thursday, November 14th. The company reported ($1.02) earnings per share (EPS) for the quarter. The firm had revenue of $26.00 million during the quarter, compared to analyst estimates of $3.10 million.

About Venus Concept

Venus Concept Inc operates as a medical aesthetic technology company worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-treatment platform to address the aesthetic procedures without surgery or downtime; Venus Legacy, an advanced device that resolves challenging face and body aesthetic needs; Venus Velocity, a diode laser for hair removal; Venus Fiore, which addresses internal vaginal health restoration, labia skin tightening, and mons pubis reduction; Venus Viva, a customizable skin resurfacing device that allows operator control of ablation and coagulation for resolving the appearance of mild to severe skin damage for various skin types; Venus Freeze Plus, an anti-aging system for non-invasive skin tightening; and Venus Bliss, a solution for the fat reduction category.

Recommended Story: What does the Producer Price Index (PPI) tell investors?

Get a free copy of the Zacks research report on Venus Concept (VERO)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with's FREE daily email newsletter.